Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
2.300
+0.020 (0.88%)
Nov 21, 2024, 11:55 AM EST - Market open

Alpha Tau Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
8.739.2611.252.341.71.37
Research & Development
26.9826.4220.8911.457.546.64
Operating Expenses
35.7135.6832.1413.799.248.01
Operating Income
-35.71-35.68-32.14-13.79-9.24-8.01
Interest Expense
-0.53-0.08----
Interest & Investment Income
4.834.831.790.210.610.78
Currency Exchange Gain (Loss)
-0.21-0.210.41-0.410.1-0.08
Other Non Operating Income (Expenses)
1.991.99-3.81-13.27-0.19-1.01
Pretax Income
-29.63-29.14-33.74-27.26-8.72-8.32
Income Tax Expense
0.010.020.020.010.160.15
Earnings From Continuing Operations
-29.64-29.16-33.76-27.27-8.88-8.46
Minority Interest in Earnings
-----0.1
Net Income
-29.64-29.16-33.76-27.27-8.88-8.37
Net Income to Common
-29.64-29.16-33.76-27.27-8.88-8.37
Shares Outstanding (Basic)
706964414034
Shares Outstanding (Diluted)
706964414034
Shares Change (YoY)
0.73%9.20%56.74%0.64%19.10%-
EPS (Basic)
-0.42-0.42-0.53-0.67-0.22-0.25
EPS (Diluted)
-0.42-0.42-0.53-0.67-0.22-0.25
Free Cash Flow
--24.36-24.78-14.74-11.02-8.2
Free Cash Flow Per Share
--0.35-0.39-0.36-0.27-0.24
EBITDA
-34.57-34.61-31.16-13.01-9.16-7.94
D&A For EBITDA
1.151.070.980.780.090.07
EBIT
-35.71-35.68-32.14-13.79-9.24-8.01
Source: S&P Capital IQ. Standard template. Financial Sources.